These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1829928)

  • 1. Phase II study of navelbine in advanced renal cell carcinoma.
    Canobbio L; Boccardo F; Guarneri D; Calabria C; Decensi A; Curotto A; Martorana G; Giuliani L
    Eur J Cancer; 1991; 27(6):804-5. PubMed ID: 1829928
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of N-methylformamide for advanced renal cell carcinoma.
    Sternberg CN; Yagoda A; Scher HI; Hollander P
    Cancer Treat Rep; 1986 May; 70(5):681-2. PubMed ID: 3708620
    [No Abstract]   [Full Text] [Related]  

  • 3. Vinblastine in metastatic renal cell carcinoma: EORTC phase II trial 30882. The EORTC Genitourinary Group.
    Fosså SD; Droz JP; Pavone-Macaluso MM; Debruyne FJ; Vermeylen K; Sylvester R
    Eur J Cancer; 1992; 28A(4-5):878-80. PubMed ID: 1524914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
    Gams RA; Nelson O; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):921-2. PubMed ID: 3521848
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC Lung Cancer Cooperative Group.
    Jassem J; Karnicka-Młodkowska H; van Pottelsberghe C; van Glabbeke M; Noseda MA; Ardizzoni A; Gozzelino F; Planting A; van Zandwijk N
    Eur J Cancer; 1993; 29A(12):1720-2. PubMed ID: 8398301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of vindesine sulfate in the therapy for advanced renal carcinoma.
    Wong PP; Yagoda A; Currie VE; Young CW
    Cancer Treat Rep; 1977 Dec; 61(9):1727-9. PubMed ID: 340038
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. Clinical Community Oncology Program.
    Sternberg CN; Yagoda A; Scher H; Bosl G; Dershaw D; Rosado K; Houston C; Rosenbluth R; Vinciguerra V; Boselli B
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):753-4. PubMed ID: 2523810
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
    Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
    Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma.
    Elson PJ; Kvols LK; Vogl SE; Glover DJ; Hahn RG; Trump DL; Carbone PP; Earle JD; Davis TE
    Invest New Drugs; 1988 Jun; 6(2):97-103. PubMed ID: 3170135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoimmunotherapy with low dose vinorelbine and interleukin-2 in treatment of patients with metastatic renal cell carcinoma.
    Mencoboni MP; Tredici S; Varaldo M; Queirolo G; Durand F; Rebella L; Galbusera V; Pannacciulli IM; Ghio R
    Neoplasma; 2006; 53(4):333-6. PubMed ID: 16830062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of vinblastine plus nifedipine (VN) in patients with advanced renal cell carcinoma (RCC). Brazilian Oncology Trials Group.
    Schwartsmann G; Medina de Cunha F; Silveira LA; Salgado G; Thereza MS; Vinholes J; Preger P; Segal F
    Ann Oncol; 1991 Jun; 2(6):443. PubMed ID: 1768632
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitozolomide in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
    van Oosterom AT; Stoter G; Bono AV; Splinter TA; Fossa SD; Verbaeys AJ; de Mulder PH; de Pauw M; Sylvester R
    Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1249-50. PubMed ID: 2767112
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase-II study of Navelbine in advanced breast cancer.
    Canobbio L; Boccardo F; Pastorino G; Brema F; Martini C; Resasco M; Santi L
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):33-6. PubMed ID: 2711204
    [No Abstract]   [Full Text] [Related]  

  • 14. TCNU in advanced renal cancer. Phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
    Van Oosterom AT; Droz JP; Fossa ST; Bono AV; Splinter TA; Verbaeys AJ; Keizer J; De Pauw M; Sylvester R
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1889-90. PubMed ID: 2632270
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of sulofenur (LY186641) in measurable metastatic renal cancer.
    Weinerman B; Eisenhauer E; Stewart D; Mertens W; Tannock I; Venner P; Spaulding R
    Ann Oncol; 1992 Jan; 3(1):83-4. PubMed ID: 1606075
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase I-II trial of gallium nitrate for advanced hypernephroma.
    Schwartz S; Yagoda A
    Anticancer Res; 1984; 4(4-5):317-8. PubMed ID: 6486736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
    Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
    J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of elliptinium in advanced renal cell carcinoma.
    Caillé P; Mondesir JM; Droz JP; Kerbrat P; Goodman A; Ducret JP; Theodore C; Spielman M; Rouëssé J; Amiel JL
    Cancer Treat Rep; 1985; 69(7-8):901-2. PubMed ID: 4016798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma.
    Berlin J; King AC; Tutsch K; Findlay JW; Kohler P; Collier M; Clendeninn NJ; Wilding G
    Invest New Drugs; 1994; 12(2):137-41. PubMed ID: 7860231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Navelbine (vinorelbine): new antitumoral agent. Biarritz, November 2-3, 1989].
    Lhommé C
    Rev Prat; 1990 Sep; 40(19):1780-1. PubMed ID: 2171131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.